Advances in Molecular Therapeutics for Retinal Disease
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 30 October 2026 | Viewed by 198
Special Issue Editor
2. Department of Ophthalmology, Aarhus University Hospital, Aarhus, Denmark
Interests: retinal disease; diabetic retinopathy; age-related macular degeneration; retinal gene therapy; animal modeling; clinical ophthalmology
Special Issue Information
Dear Colleagues,
Despite advances in therapy, visual impairment and blindness are still prevalent. In particular, the burden of age-related diseases such as glaucoma and age-related macular degeneration is increasing due to the aging populations across the globe. Successful solutions to the unmet needs in retinal disease management require improved understanding of disease mechanisms to identify novel therapeutic targets and improve patient selection. Furthermore, overcoming limitations of current therapies necessitates the development of improved therapeutic platforms and delivery vehicles. Hence, the aim of this Special Issue is to summarize and enlarge the knowledge of retinal disease mechanisms and therapeutic advances.
Therefore, authors are invited to submit original research and review articles exploring molecular mechanisms of retinal disease and developments in retinal therapeutics.
Topics include, but are not limited to, the following:
- Laboratory and clinical studies exploring retinal disease mechanisms;
- Novel therapeutic platforms and delivery vehicles;
- Preclinical and clinical studies of novel therapeutics for retinal disease.
Dr. Thomas Stax Jakobsen
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- retinal disease
- retinal degeneration
- retinal gene therapy
- regenerative medicine
- neuroprotection
- delivery vehicles
- viral vectors
- nanoparticles
- cell therapy
- anti-angiogenic therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
